What we found on the web about Gaboxadol
Gaboxadol was an experimental sleeping pill developed by Lundbeck and Merck. In March, 2007, Merck and H. Lundbeck cancelled work on the drug, citing safety concerns and the ...
A GABA agonist is a drug which acts to stimulate or increase the action at the GABA ... Gaboxadol · Isonipecotic acid · Muscimol. GABAB receptor: Baclofen · Phenibut · GHB; positive ...
Date/Time Thumbnail Dimensions User Comment; current: 23:16, 28 March 2007: 820×575 (3 KB) Fvasconcellos (Talk | contribs) (== Summary == {{Information |Description= {{w|Skeletal ...
The drug, Gaboxadol, has entered phase III development for the treatment of insomnia after promising results from phase II trials. Reviewed by The Sleep Medicine Center at The ...
APSS: Gaboxadol Improves Sleep in Elderly By W. A. Thomasson Special to DG News. CHICAGO, IL -- June 11, 2001 -- Gaboxadol, a GAGA agonist not currently approved for clinical use ...
Study Type: Interventional: Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety Study: Official Title: A Prospective Randomised Double ...
Abstract: The present invention is directed to novel acid salt forms and base salt forms of the compound gabaoxadol (4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol) and ...
Gaboxadol is a direct-acting GABA-A receptor agonist with the chemical name 7-tetra hydroisoxazolo[5, 4-c]pyridin-3-ol (THIP). Gaboxadol has a mode of action different from that of ...
These product press releases are intended for use in the United States only. Countries outside of the U.S. may have different regulatory requirements and review practices that may ...
Abstract: The present invention relates to a method for treating impaired respiratory function in a human patient suffering from sleep apnea, such as central sleep apnea ...
An experimental drug called gaboxadol may soon help millions of bleary-eyed insomniacs get to sleep, and a multi-center team of U.S. scientists believes they've pinpointed just how ...
Here is what users have to say about Gaboxadol

Gaboxadol was an experimental sleeping pill developed by Lundbeck and Merck. In March, 2007, Merck and H. Lundbeck cancelled work on the drug, citing safety concerns and the failure of an efficacy trial. It acts on the GABA system, but in a very different way than benzodiazepines and 'z-drugs' (zolpidem, zaleplon, and zopiclone). Lundbeck states that gaboxadol also increases deep sleep (stage 4).

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!